Active ingredientTranylcypromineCat. No. P-T178-001CAS 155-09-9Family · Pharmaceutical analytical standards
Tranylcypromine
A monoamine oxidase (MAO) inhibitor antidepressant, synthesised in 1948 as an amphetamine analogue; its action on MAO was discovered in 1959 and it reached the UK as an antidepressant in 1960. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Unlike the first MAO inhibitors, such as iproniazid, it is not derived from hydrazine; in 2006 it was found to also block LSD1, an enzyme that regulates gene activity.
Go to the active ingredient →Active ingredientTranylcypromineCat. No. P-T178-001CAS 155-09-9
Active ingredientTranylcypromine SulfateCat. No. P-T178-002CAS 13492-01-8
Pharmacopoeial impurityTranylcypromine USP Related Compound A HydrochlorideCat. No. P-T178-003CAS 54779-58-7
Isotopically labelledTranylcypromine-d5Cat. No. P-T178-005
Impurity(-)-Tranylcypromine HClCat. No. P-T178-008CAS 37388-05-9
ImpurityCinnamylamine HydrochlorideCat. No. P-T178-009CAS 5586-89-0
Impuritycis-2-PhenylcyclopropanecarbohydrazideCat. No. P-T178-010CAS 17364-52-2
Impurityrac-trans-Tranylcypromine HClCat. No. P-T178-011CAS 1986-47-6
ImpurityTranylcypromine Impurity 1Cat. No. P-T178-012CAS 14561-40-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.